Abstract
Improvement in long-term survival in patients with acute childhood leukemia has led to the need for monitorization of chemotherapy-related morbidity and mortality. This study included 60 patients with acute lymphoblastic leukemia that were in remission for at least 2 years and 30 healthy controls. Systolic and diastolic function of myocardium was evaluated using conventional echocardiography and tissue Doppler imaging of the left ventricle, interventricular septum and right ventricle. Median age of patients was 11.7 years (range 10–14.9 years), and the median duration of remission was 4 years (range 2.5–5 years). All patients were treated with a low cumulative dose of adriamycin (100 mg/m2) according to the St. Jude Total-XIIIA protocol. The ejection fraction (EF) and fractional shortening were normal in the patient and control groups, even though EF values were significantly lower in the patients (69.5 ± 2.3 vs. 72.7 ± 3 %, P < 0.01). Myocardial systole (S m), early diastole (E m) and late diastole (A m) velocities in all segments of the myocardium were significantly lower in the patient group (P < 0.01 for all segments). Cardiotoxicity was noted in all segments of the myocardium in the patient group, despite the fact that they were all treated with a low cumulative dose of adriamycin. Based on these findings, we think that there is no safe dose for anthracyclines and periodic echocardiographic evaluation of both the left and right ventricles must be performed in all patients treated with anthracyclines, even at low doses.
Similar content being viewed by others
References
ACC/AHA/ASE (2003) Guideline update for the clinical application of echocardiography: a report of the ACC/AHA/ASE Committee to update the 1997 guidelines. Circulation 2003(108):1146–1162
Adams MJ, Lipshultz SE (2005) Pathophysiology of anthracycline and radiation associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 44:600–606
Alehan D, Sahin M, Varan A, Yıldırım I, Küpeli S, Büyükpamukçu M (2012) Tissue Doppler evaluation of systolic and diastolic cardiac functions in long term survivors of Hodgkin lymphoma. Pediatr Blood Cancer 58:250–255
Ayhan SS, Özdemir K, Kayrak M, Bacaksiz A, Vatankulu MA, Eren Ö et al (2012) The evaluation of doxorubicin-induced cardiotoxicity: comparison of Doppler and tissue Doppler-derived myocardial performance index. Cardiol J 19:363–368
Baysal T, Koksal Y, Oran B, Sen M, Unal E, Cimen D (2010) Cardiac functions evaluated with tissue Doppler imaging in childhood cancers treated with anthracyclines. Pediatr Hematol Oncol 27:13–23
Dragulescu A, Mertens LL (2010) Developments in echocardiographic techniques for the evaluation of ventricular function in children. Arch Cardiovasc Dis 103:603–614
Eidem BW, Sapp BG, Suarez CR, Cetta F (2001) Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol 87:1120–1122
Galderisi M, Cattaneo F, Mondillo S (2007) Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologies. Cardiovascular Ultrasound 5:28–41
Ganame J, Claus P, Uyttebroeck A, Renard M, D’hooge J, Bijnens B et al (2007) Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr 20:1351–1358
Garcia-Fernandez MA, Zamorano J, Azevedo J (eds) (1998) Doppler Tissue imaging. McGraw-Hill, Madrid
Guidelines and standards for performance of a pediatric echocardiogram (2006) A report from the task force of the pediatric council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413–1430
Haddy TB, Mosher RB, Reaman GH (2009) Late effects in long-term survivors after treatment for childhood acute leukemia. Clin Pediatr 48:601–608
Karakurt C, Koçak G, Ozgen U (2008) Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy. Echocardiography 25:880–887
Kocabaş A, Kardelen F, Ertuğ H, Aldemir-Kocabaş B, Tosun Ö, Yeşilipek A et al (2014) Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles. Pediatr Cardiol 35(1):82–88
Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2236–2629
Lipshultz SE, Alvarez JA, Scully RE (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94:525–533
Ness KK, Armenian SH, Kadan-Lottick N, Gurney JG (2011) Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev Hematol 4:185–197
Nikitin NP, Witte KK (2004) Application of tissue Doppler imaging in cardiology. Cardiology 101:170–184
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582
Pui CH, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC et al (2000) Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children’s Research Hospital. Leukemia 14:2286–2294
Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC et al (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730–2741
Rathe M, Carlsen NL, Oxhøj H (2007) Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 48:663–667
Rathe M, Carlsen NL, Oxhøj H, Nielsen G (2010) Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia. Pediatr Blood Cancer 54:444–448
Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W et al (2008) Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the Cardiovascular Disease Task Force of the Children’s Oncology Group. Pediatrics 121:e387–e396
Temming P, Qureshi A, Hardt J, Leiper AD, Levitt G, Ancliff PJ, Webb DK (2011) Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom. Pediatr Blood Cancer 56:625–630
Trachtenberg BH, Landy DC, Franco VI, Henkel JM, Pearson EJ, Miller TL, Lipshultz SE (2011) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 32:342–353
Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B (2012) Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood. J Cancer Surviv 6:95–101
Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53:2231–2247
Author information
Authors and Affiliations
Corresponding author
Additional information
Cengiz Bayram and İlker Çetin have contributed equally to this study.
Rights and permissions
About this article
Cite this article
Bayram, C., Çetin, İ., Tavil, B. et al. Evaluation of Cardiotoxicity by Tissue Doppler Imaging in Childhood Leukemia Survivors Treated with Low-Dose Anthracycline. Pediatr Cardiol 36, 862–866 (2015). https://doi.org/10.1007/s00246-015-1096-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-015-1096-6